[Atrial natriuretic peptide as angiotensin II antagonist. A new therapeutic principle?].
Pfaffendorf
M
M
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000502:physiology* / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D013329:Structure-Activity Relationship
D000806:Angiotensin-Converting Enzyme Inhibitors; D009320:Atrial Natriuretic Factor
Atriales natriuretisches Peptid als Angiotensin-II-Antagonist. Ein neues therapeutisches Prinzip?